|1.||Lee, H: 1 article (03/2014)|
|2.||Wu, D-W: 1 article (03/2014)|
|3.||Cheng, Y-W: 1 article (03/2014)|
|4.||Lee, M-C: 1 article (03/2014)|
|5.||Wang, J: 1 article (03/2014)|
|6.||Chen, C-Y: 1 article (03/2014)|
|7.||Hamilton, G M: 1 article (06/2012)|
|8.||Emery, C A: 1 article (06/2012)|
|9.||Shrier, I: 1 article (06/2012)|
|10.||Meeuwisse, W H: 1 article (06/2012)|
|1.||Lung Neoplasms (Lung Cancer)
03/20/2014 - "Conversely, DDX3 expression was markedly elevated by wild-type (WT) p53 ectopic expression in p53-null H1299 cells, E6-knockdown TL-1 lung cancer and SiHa cervical cancer cells. "
08/01/2008 - "Secreting IL-6 levels and Mcl-1 expressions were examined by ELISA and Western blot, respectively, in HPV 16/18 E6- and E7-transfected A549 human lung cancer cells, as well as in the HPV16-infected TL-1 lung cancer cells established from lung cancer patients. "
04/01/1982 - "Results suggest that on leukemia cells from Tlaa mice, as previously reported for thymocytes from these mice, all the alloantiserum-defined TL specificities (TL.1, 2, 3, 5, 6) as well as the specificity defined by the monoclonal antibody (TL.m3) are carried by a single molecular species. "
11/01/1981 - "Analysis of the TL product on ERLD leukemia cells (TL phenotype, TL.1,2,4) indicates a single TL glycoprotein species with the TL.4 determinant (restricted to leukemias of Tlab and Tlac haplotypes) coexisting on the same glycoprotein as the Tl.1 determinant (normally expressed by thymocytes of Tlaa haplotype). "
|3.||Burkitt Lymphoma (Burkitt's Lymphoma)
|4.||Chronic Obstructive Pulmonary Disease (COPD)
|5.||Leukocyte-Adhesion Deficiency Syndrome
|1.||Interleukin-6 (Interleukin 6)
|2.||RNA (Ribonucleic Acid)
|5.||DNA (Deoxyribonucleic Acid)